Recent advances in DNA sequencing technology are making rapid, affordable genome sequencing increasingly viable in health services. This will pave the way for increasingly personalised medicine and better medical care and public health, and offers immediate benefits for patients with rare diseases and cancer. So what will it take to make clinical genome sequencing and analysis a reality?
This project is examining different aspects of clinical genome analysis in greater depth, to explain and address what barriers need to be crossed in order to use genome sequence data for practical, clinical purposes.
The PHG Foundation has been watching the development of genome sequencing technology and the potential for genomic medicine with great interest for years. In 2011 we produced the first ever appraisal of the potential impact on medical practice, which identified the challenges to prompt uptake and made specific recommendations for the UK National Health Service:
Leila is responsible for the delivery of the scientific expertise and analysis that underpin our work.More about Leila